Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease

portfolio company news

May 9

Written By MacDougall Creative

MacDougall Creative https://www.macbiocom.com

TScan Therapeutics Announces Pricing of $140 Million Public Offering

Inspirna Appoints Dr. Usman “Oz” Azam, M.D., as New Chief Executive Officer